Results 171 to 180 of about 2,755,321 (217)

Mid-level managers' perspectives on implementing isoniazid preventive therapy for people living with HIV in Ugandan health districts: a qualitative study. [PDF]

BMC Health Serv Res
Christian C, Kakande E, Nahurira V, Akatukwasa C, Atwine F, Bakanoma R, Itiakorit H, Owaraganise A, DiIeso W, Rast D, Kabami J, Peretz JJ, Shade SB, Kamya MR, Havlir DV, Chamie G, Camlin CS.   +16 more
europepmc   +1 more source

Isoniazid preventive therapy during infancy does not adversely affect growth among HIV-exposed uninfected children: Secondary analysis of data from a randomized controlled trial. [PDF]

PLoS One
Cherkos AS, LaCourse SM, Enquobahrie DA, Escudero JN, Mecha J, Matemo D, Kinuthia J, Iribarren SJ, John-Stewart G.   +8 more
europepmc   +1 more source

Strategies for isoniazid preventive therapy in HIV-positive patients who consume alcohol. [PDF]

Int J Tuberc Lung Dis
Savinkina A, Muyindike W, Hahn JA, Emenyonu NI, Fatch R, Ngabirano C, Adong J, Jacobson KR, Linas BP.   +8 more
europepmc   +1 more source

Isoniazid preventive therapy completion between July-September 2019: A comparison across HIV differentiated service delivery models in Uganda. [PDF]

PLoS One
Mugenyi L, Namuwenge PM, Ouma S, Bakashaba B, Nanfuka M, Zech J, Agaba C, Mijumbi Ojok A, Kaliba F, Bossa Kato J, Opito R, Miya Y, Katureebe C, Hirsch-Moverman Y.   +13 more
europepmc   +1 more source

Tuberculosis screening and isoniazid preventive therapy implementation: a Brazilian experience

Expert Review of Anti-Infective Therapy, 2014
Tuberculosis Preventive therapy has been used since the 1960s for both mass treatment of populations and for targeted therapy to high-risk groups such as children. The World Health Organization (WHO) recommends the use of Isoniazid preventive therapy (IPT) as one of the strategies to reduce the TB burden among people living with HIV infection. However,
Swaminathan, Soumya, Chandrasekaran, Padmapriyadarsini   +1 more
exaly   +5 more sources

Isoniazid Preventive Therapy for Tuberculosis

Chest, 1988
Contact investigation activities of the Tennessee Department of Health and Environment (TDHE) Tuberculosis (TB) Control Program from 1979 to 1985 were reviewed.
Jay B. Mehta, Asim K. Dutt, Leo Harvill, Warren Henry   +3 more
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Isoniazid preventive therapy for all: are we ready?

International Journal of Tuberculosis and Lung Disease, 2011
H L Rieder, H L Rieder
exaly   +4 more sources

Isoniazid preventive therapy in areas of high isoniazid resistance.

Archives of internal medicine, 1995
Previous decision analyses of isoniazid preventive therapy for low-risk tuberculin reactors aged 20 to 34 years have not accounted for the recently increased isoniazid resistance rate. Drug resistance trends could also affect the decision to use isoniazid preventive therapy for patients with recent conversion of tuberculin skin tests who are ...
T R, Sterling, W T, Brehm, T R, Frieden
openaire   +3 more sources

Perspective: Preventive Isoniazid Therapy and the Liver

Chest, 1992
The preventive use of isoniazid (INH) has been controversial since 1975, but official agencies continue to advocate the procedure. Cost-effectiveness and risk benefit studies of preventive INH use have come to conflicting conclusions. A review of eight such studies indicates an increasing tendency to minimize INH hepatotoxicity and to disregard the ...
H L, Israel, J E, Gottlieb, W C, Maddrey
openaire   +2 more sources

Isoniazid Preventive Therapy

Archives of Internal Medicine, 1996
I am responding to the recent article entitled "Isoniazid Preventive Therapy in Areas of High Isoniazid Resistance," by Sterling et al. 1 This decision analysis attempts to evaluate the life expectancies for tuberculin reactors who take isoniazid prophylaxis compared with those who have preventive treatment withheld.
openaire   +1 more source